Dicloxacillin
- Product NDC
- 62135-970
- Requested package NDC
- 62135-970-40
- 11-digit product format
- 621350970
- Labeler code
- 62135
- Product ID
- 62135-970_5fd975fe-1c44-b430-e063-6394a90a4697
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dicloxacillin Sodium
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA061454
- Marketing category
- ANDA
- Marketing start
- 1971-04-01
- Substance
- DICLOXACILLIN SODIUM
- Active strength
- 125 mg/1
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A061454-001 | DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | ||
| A061454-002 | DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | ||
| A061454-003 | DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A061454-002 | DICLOXACILLIN SODIUM | EQ 125MG BASE | CAPSULE / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A061454-003 | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A061454-001 | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A061454-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A061454-003 | AB | 1 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | A061454-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A061454-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A061454-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A061454-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A061454-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A061454-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A061454-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A061454-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A061454-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A061454-003 | AB | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dicloxacillin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DICLOXACILLIN SODIUM | 125 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4HZT2V9KX0 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5d291f1b-6c9a-4e47-bc26-c1b8c0fd667c | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dicloxacillin | DICLOXACILLIN SODIUM | Chartwell RX, LLC | 5d291f1b-6c9a-4e47-bc26-c1b8c0fd667c | 2026-11-09 | Warnings, Adverse reactions | 061454 ANDA061454 62135-970-40 62135-970 62135097040 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 62135-970-40 | 62135097040 | 40 CAPSULE in 1 BOTTLE (62135-970-40) | 40 capsule | 2026-11-03 | No | No | Current |